Free Trial

Pallas Capital Advisors LLC Has $4.43 Million Holdings in Danaher Co. (NYSE:DHR)

Danaher logo with Multi-Sector Conglomerates background

Pallas Capital Advisors LLC lifted its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 132.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 19,278 shares of the conglomerate's stock after acquiring an additional 10,976 shares during the period. Pallas Capital Advisors LLC's holdings in Danaher were worth $4,425,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. Fort Pitt Capital Group LLC boosted its holdings in Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate's stock worth $66,194,000 after acquiring an additional 7,421 shares in the last quarter. Good Life Advisors LLC acquired a new stake in Danaher in the 3rd quarter valued at $217,000. Harvest Portfolios Group Inc. increased its stake in Danaher by 1.2% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate's stock valued at $56,233,000 after purchasing an additional 2,465 shares in the last quarter. ORG Partners LLC raised its holdings in Danaher by 1,212.8% during the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock worth $636,000 after buying an additional 2,559 shares during the last quarter. Finally, Stifel Financial Corp lifted its stake in shares of Danaher by 1.3% in the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate's stock valued at $235,583,000 after buying an additional 11,216 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on DHR. UBS Group dropped their price target on shares of Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a research report on Wednesday, October 23rd. Barclays decreased their price target on Danaher from $285.00 to $275.00 and set an "equal weight" rating for the company in a report on Wednesday, October 23rd. Wolfe Research raised shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price objective on the stock in a report on Thursday, October 31st. Evercore ISI increased their target price on shares of Danaher from $275.00 to $278.00 and gave the company an "outperform" rating in a report on Tuesday, October 1st. Finally, Scotiabank initiated coverage on shares of Danaher in a research report on Monday, December 23rd. They set a "sector perform" rating and a $265.00 price target on the stock. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $286.80.

Check Out Our Latest Analysis on DHR

Danaher Stock Performance

Shares of DHR traded up $4.76 during trading hours on Monday, hitting $239.83. The company's stock had a trading volume of 3,299,741 shares, compared to its average volume of 2,915,061. The company has a market cap of $173.22 billion, a price-to-earnings ratio of 45.77, a PEG ratio of 4.32 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The business has a 50 day simple moving average of $235.67 and a two-hundred day simple moving average of $253.73. Danaher Co. has a 52-week low of $222.53 and a 52-week high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analysts' expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business's revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.02 EPS. On average, equities analysts expect that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. The ex-dividend date of this dividend is Friday, December 27th. Danaher's dividend payout ratio is presently 20.61%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

See Also

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines